Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 18-21 May 2026
WHY IT MATTERS
If you have a rare disease, one of these eight newly approved medicines might be a treatment option available in Europe — check with your doctor to see if any match your condition.
The European Medicines Agency approved eight new medicines in May 2026. The article mentions a few specific drugs, including Jascayd (nerandomilast) and Boey (trenibotulinumtoxinE), though details about what diseases they treat are incomplete in this announcement.
Source: European Medicines Agency (EMA) Description: Eight new medicines recommended for approvalEMA’s human medicines committee (CHMP) recommended eight medicines for approval at its May 2026 meeting.Jascayd (nerandomilast)…, CHMP statistics Key figures from the May 2026 CHMP meeting are represented in the graphic below.  , CHMP statistics:…, Positive recommendations on new medicines, Boey INN trenibotulinumtoxinE Marketing authorisation applicant AbbVie Deutschland GmbH & Co Therapeutic indication Temporary imp Published: 2026-05-22T10:50:00.000Z Note: EMA announcements cover medicines approved in the EU. Orphan designations may not yet be available in the US.
ASK YOUR DOCTOR
Ask your doctor at your next appointment whether any of these eight newly approved medicines might be suitable for your condition, especially if you live in the EU.